282 Followers on Owler

Bavarian Nordic

is a Denmark-based biotechnology company that develops and commercializes vaccines for the treatment of cancer and infectious diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Bavarian Nordic

is a Denmark-based biotechnology company that develops and commercializes vaccines for the treatment of cancer and infectious diseases... Read more
Bavarian Nordic President & CEO: Paul Chaplin

President & CEO

Paul Chaplin

CEO Approval Rating

90/100

1994

PublicAcquisition Pending from Innosera ApSOtherBAVA

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$906.1M
Employees
1,609
Funding
$279.4M
Acquisitions
2

News

Product Launch
Sep 05, 2025
Manufacturing Chemist
Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK
Acquisition
Jul 15, 2025
bavarian-nordic.com
Bavarian Nordic Was acquired by Innosera ApS for $3B

Bavarian Nordic Competitors

1Symphogen
2Genmab
3MorphoSys
4Nuevolution
5IOmet Pharma
6Juno Therapeutics
7NexImmune
8Janssen
9Aura
10Sutro Biopharma
Unlock 12 + competitors

Trending Companies